{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T10:34:08Z","timestamp":1762079648849,"version":"3.44.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.ahj.2018.06.009","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T00:14:41Z","timestamp":1529626481000},"page":"53-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Dyskalemias and adverse events associated with discharge potassium in acute myocardial infarction"],"prefix":"10.1016","volume":"205","author":[{"given":"Hong","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonas","family":"Fax\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karolina","family":"Szummer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Csaba P.","family":"Kovesdy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomas","family":"Jernberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan Jes\u00fas","family":"Carrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ahj.2018.06.009_bb0005","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1056\/NEJM199808133390707","article-title":"Hypokalemia","volume":"339","author":"Gennari","year":"1998","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ahj.2018.06.009_bb0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.kisu.2016.01.002","article-title":"Epidemiology of hyperkalemia: an update","volume":"6","author":"Kovesdy","year":"2016","journal-title":"Kidney Int Suppl"},{"issue":"17","key":"10.1016\/j.ahj.2018.06.009_bb0015","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1093\/eurheartj\/ehy100","article-title":"Serum potassium and adverse outcomes across the range of kidney function: a CKD Prognosis Consortium meta-analysis","volume":"39","author":"Kovesdy","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2018.06.009_bb0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ijcard.2017.07.035","article-title":"Incidence and determinants of hyperkalemia and hypokalemia in a large healthcare system","volume":"245","author":"Nilsson","year":"2017","journal-title":"Int J Cardiol"},{"issue":"15 Suppl","key":"10.1016\/j.ahj.2018.06.009_bb0025","first-page":"s307","article-title":"The burden of hyperkalemia in patients with cardiovascular and renal disease","volume":"21","author":"Dunn","year":"2015","journal-title":"Am J Manag Care"},{"issue":"7","key":"10.1016\/j.ahj.2018.06.009_bb0030","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00467-016-3411-8","article-title":"Potassium: friend or foe?","volume":"32","author":"Rodan","year":"2017","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/j.ahj.2018.06.009_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.1182","article-title":"Factors associated with underuse of mineralocorticoid receptor antagonists in heart failure with reduced ejection fraction: an analysis of 11 215 patients from the Swedish Heart Failure Registry","author":"Savarese","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"7","key":"10.1016\/j.ahj.2018.06.009_bb0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.005428","article-title":"Hyperkalemia after initiating renin-angiotensin system blockade: the Stockholm Creatinine Measurements (SCREAM) Project","volume":"6","author":"Bandak","year":"2017","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ahj.2018.06.009_bb0045","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2796.2009.02204.x","article-title":"Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register","volume":"268","author":"Szummer","year":"2010","journal-title":"J Intern Med"},{"issue":"16","key":"10.1016\/j.ahj.2018.06.009_bb0050","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.jacc.2016.02.033","article-title":"Early aldosterone blockade in acute myocardial infarction: the ALBATROSS randomized clinical trial","volume":"67","author":"Beygui","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ahj.2018.06.009_bb0055","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jcin.2015.10.035","article-title":"Randomized control of sympathetic drive with continuous intravenous esmolol in patients with acute ST-segment elevation myocardial infarction: the BEtA-Blocker Therapy in Acute Myocardial Infarction (BEAT-AMI) trial","volume":"9","author":"Er","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"issue":"1","key":"10.1016\/j.ahj.2018.06.009_bb0060","first-page":"18","article-title":"Serum potassium levels, cardiac arrhythmias, and mortality following non-ST-elevation myocardial infarction or unstable angina: insights from MERLIN-TIMI 36","volume":"6","author":"Patel","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"20","key":"10.1016\/j.ahj.2018.06.009_bb0065","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1056\/NEJMoa032292","article-title":"Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both","volume":"349","author":"Pfeffer","year":"2003","journal-title":"N Engl J Med"},{"issue":"9335","key":"10.1016\/j.ahj.2018.06.009_bb0070","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S0140-6736(02)09895-1","article-title":"Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan","volume":"360","author":"Dickstein","year":"2002","journal-title":"Lancet"},{"issue":"25","key":"10.1016\/j.ahj.2018.06.009_bb0075","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1056\/NEJM199512213332503","article-title":"A clinical trial of the angiotensin-converting-enzyme inhibitor trandolapril in patients with left ventricular dysfunction after myocardial infarction. Trandolapril Cardiac Evaluation (TRACE) Study Group","volume":"333","author":"Kober","year":"1995","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.ahj.2018.06.009_bb0080","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1001\/jamainternmed.2015.6102","article-title":"Representation of patients with kidney disease in trials of cardiovascular interventions: an updated systematic review","volume":"176","author":"Konstantinidis","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"20","key":"10.1016\/j.ahj.2018.06.009_bb0085","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/hrt.2010.198804","article-title":"The SwedishWeb-System for Enhancement and Development of Evidence-Based Care in Heart Disease Evaluated According to Recommended Therapies (SWEDEHEART)","volume":"96","author":"Jernberg","year":"2010","journal-title":"Heart"},{"issue":"1","key":"10.1016\/j.ahj.2018.06.009_bb0090","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ckj\/sfv117","article-title":"The Stockholm CREAtinine Measurements (SCREAM) project: protocol overview and regional representativeness","volume":"9","author":"Runesson","year":"2016","journal-title":"Clin Kidney J"},{"issue":"12","key":"10.1016\/j.ahj.2018.06.009_bb0095","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1093\/ndt\/gfw354","article-title":"Prevalence and recognition of chronic kidney disease in Stockholm healthcare","volume":"31","author":"Gasparini","year":"2016","journal-title":"Nephrol Dial Transplant"},{"issue":"20","key":"10.1016\/j.ahj.2018.06.009_bb0100","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1093\/eurheartj\/ehm355","article-title":"Universal definition of myocardial infarction","volume":"28","author":"Thygesen","year":"2007","journal-title":"Eur Heart J"},{"issue":"18","key":"10.1016\/j.ahj.2018.06.009_bb0105","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1053\/euhj.2000.2305","volume":"21","year":"2000","journal-title":"Eur Heart J"},{"issue":"23","key":"10.1016\/j.ahj.2018.06.009_bb0110","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1056\/NEJM198312083092303","article-title":"Hypokalemia from beta2-receptor stimulation by circulating epinephrine","volume":"309","author":"Brown","year":"1983","journal-title":"N Engl J Med"},{"issue":"214","key":"10.1016\/j.ahj.2018.06.009_bb0115","first-page":"133","article-title":"Plasma catecholamines in patients with acute myocardial infarction and in cardiac arrest","volume":"54","author":"Little","year":"1985","journal-title":"Q J Med"},{"issue":"8338","key":"10.1016\/j.ahj.2018.06.009_bb0120","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1016\/S0140-6736(83)92140-2","article-title":"Prior thiazide diuretic treatment increases adrenaline-induced hypokalaemia","volume":"1","author":"Struthers","year":"1983","journal-title":"Lancet"},{"issue":"14","key":"10.1016\/j.ahj.2018.06.009_bb0125","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1056\/NEJMoa030207","article-title":"Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction","volume":"348","author":"Pitt","year":"2003","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ahj.2018.06.009_bb0130","first-page":"331","article-title":"The incidence of diuretic-induced hypokalemia in two distinct clinic settings","volume":"2","author":"Bloomfield","year":"1986","journal-title":"J Clin Hypertens"},{"issue":"7","key":"10.1016\/j.ahj.2018.06.009_bb0135","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V871179","article-title":"Hypokalemia\u2014consequences, causes, and correction","volume":"8","author":"Weiner","year":"1997","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.ahj.2018.06.009_bb0140","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1093\/ehjcvp\/pvv026","article-title":"Short-term mortality risk of serum potassium levels in acute heart failure following myocardial infarction","volume":"1","author":"Krogager","year":"2015","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"23","key":"10.1016\/j.ahj.2018.06.009_bb0145","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003778","article-title":"The association between normal-range admission potassium levels in Israeli patients with acute coronary syndrome and early and late outcomes","volume":"95","author":"Shlomai","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.ahj.2018.06.009_bb0150","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.ijcard.2016.07.024","article-title":"The effect of serum potassium level on in-hospital and long-term mortality in ST elevation myocardial infarction","volume":"221","author":"Keskin","year":"2016","journal-title":"Int J Cardiol"},{"issue":"8","key":"10.1016\/j.ahj.2018.06.009_bb0155","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.amjcard.2014.01.402","article-title":"Relation of serum potassium level to long-term outcomes in patients with acute myocardial infarction","volume":"113","author":"Choi","year":"2014","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2018.06.009_bb0160","doi-asserted-by":"crossref","first-page":"e368","DOI":"10.1016\/j.ijcard.2013.12.296","article-title":"Serum potassium levels and long-term post-discharge mortality in acute myocardial infarction","volume":"172","author":"Shiyovich","year":"2014","journal-title":"Int J Cardiol"},{"issue":"2","key":"10.1016\/j.ahj.2018.06.009_bb0165","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1001\/jama.2011.1967","article-title":"Serum potassium levels and mortality in acute myocardial infarction","volume":"307","author":"Goyal","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2018.06.009_bb0170","series-title":"Signs and symptoms of electrolyte disorders: clinical disorders of fluid and electrolyte metabolism","first-page":"499","author":"FH E","year":"1980"},{"key":"10.1016\/j.ahj.2018.06.009_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/ejhf.1199","article-title":"Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists","author":"Trevisan","year":"2018","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1016\/j.ahj.2018.06.009_bb0180","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002011","article-title":"Validity of the International Classification of Diseases 10th revision code for hyperkalaemia in elderly patients at presentation to an emergency department and at hospital admission","volume":"2","author":"Fleet","year":"2012","journal-title":"BMJ Open"},{"issue":"5 Suppl. 1","key":"10.1016\/j.ahj.2018.06.009_bb0185","first-page":"S1","volume":"43","year":"2004","journal-title":"Am J Kidney Dis"},{"issue":"16","key":"10.1016\/j.ahj.2018.06.009_bb0190","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1161\/hc4101.096153","article-title":"Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association","volume":"104","author":"Schoolwerth","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ahj.2018.06.009_bb0195","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012818","article-title":"Adherence to guidelines for creatinine and potassium monitoring and discontinuation following renin-angiotensin system blockade: a UK general practice-based cohort study","volume":"7","author":"Schmidt","year":"2017","journal-title":"BMJ Open"},{"issue":"9","key":"10.1016\/j.ahj.2018.06.009_bb0200","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/pds.3994","article-title":"Appropriate baseline laboratory testing following ACEI or ARB initiation by Medicare FFS beneficiaries","volume":"25","author":"Maciejewski","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ahj.2018.06.009_bb0205","doi-asserted-by":"crossref","DOI":"10.1093\/ehjqcco\/qcy019","article-title":"A real-world cohort study on the quality of potassium and creatinine monitoring during initiation of mineralocorticoid receptor antagonists in patients with heart failure","author":"Nilsson","year":"2018","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"issue":"3","key":"10.1016\/j.ahj.2018.06.009_bb0210","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1410853","article-title":"Patiromer in patients with kidney disease and hyperkalemia receiving RAAS inhibitors","volume":"372","author":"Weir","year":"2015","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.ahj.2018.06.009_bb0215","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1001\/jama.2014.15688","article-title":"Effect of sodium zirconium cyclosilicate on potassium lowering for 28 days among outpatients with hyperkalemia: the HARMONIZE randomized clinical trial","volume":"312","author":"Kosiborod","year":"2014","journal-title":"JAMA"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318301911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318301911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:00:27Z","timestamp":1757570427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870318301911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":43,"alternative-id":["S0002870318301911"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2018.06.009","relation":{},"ISSN":["0002-8703"],"issn-type":[{"type":"print","value":"0002-8703"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dyskalemias and adverse events associated with discharge potassium in acute myocardial infarction","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2018.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}